Benjamin Landry, General Counsel at Health Catalyst, Inc. (HCAT), sold 27,654 shares at $4.55 ($126K) on 2025-03-06, disclosed to the SEC on 2025-03-10.
Scheduled sale ($126k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.55 | 13,827 | $63K | 50.0% |
| 2 | $4.55 | 13,827 | $63K | 50.0% |
| Total | $4.55 avg | 27,654 | $126K | 100% |
| Filing → |
| HCAT | SELL | 2025-06-09 | $24K | — | Filing → |
| HCAT | SELL | 2025-01-10 | $19K | — | Filing → |
| HCAT | SELL | 2024-12-10 | $321K | — | Filing → |